Elucidating the precise pharmacological mechanism of motion (MOA) of naturally transpiring compounds is often demanding. Although Tarselli et al. (60) created the main de novo synthetic pathway to conolidine and showcased this naturally taking place compound efficiently suppresses responses to both chemically induced and inflammation-derived pain,